HRP20190162T1 - Lactobacillus reuteri atcc pta 6475 za uporabu za sprječavanje ili liječenje gubitka kosti kod sisavaca - Google Patents
Lactobacillus reuteri atcc pta 6475 za uporabu za sprječavanje ili liječenje gubitka kosti kod sisavacaInfo
- Publication number
- HRP20190162T1 HRP20190162T1 HRP20190162TT HRP20190162T HRP20190162T1 HR P20190162 T1 HRP20190162 T1 HR P20190162T1 HR P20190162T T HRP20190162T T HR P20190162TT HR P20190162 T HRP20190162 T HR P20190162T HR P20190162 T1 HRP20190162 T1 HR P20190162T1
- Authority
- HR
- Croatia
- Prior art keywords
- mammals
- selection
- lactic acid
- acid bacteria
- bone loss
- Prior art date
Links
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title 2
- 241000894006 Bacteria Species 0.000 title 1
- 206010065687 Bone loss Diseases 0.000 title 1
- 241000124008 Mammalia Species 0.000 title 1
- 235000014655 lactic acid Nutrition 0.000 title 1
- 239000004310 lactic acid Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261689338P | 2012-06-04 | 2012-06-04 | |
| EP13800449.4A EP2854826B9 (en) | 2012-06-04 | 2013-06-04 | Lactobacillus reuteri atcc pta 6475 for use in prevention or treatment of bone loss in mammals |
| PCT/SE2013/050646 WO2013184064A1 (en) | 2012-06-04 | 2013-06-04 | Selection and use of lactic acid bacteria preventing bone loss in mammals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20190162T1 true HRP20190162T1 (hr) | 2019-04-05 |
Family
ID=49712339
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20190162TT HRP20190162T1 (hr) | 2012-06-04 | 2019-01-24 | Lactobacillus reuteri atcc pta 6475 za uporabu za sprječavanje ili liječenje gubitka kosti kod sisavaca |
Country Status (17)
| Country | Link |
|---|---|
| US (4) | US20150150917A1 (hr) |
| EP (2) | EP3456334B1 (hr) |
| JP (1) | JP6193981B2 (hr) |
| KR (2) | KR20150028968A (hr) |
| CN (1) | CN104755091B (hr) |
| AU (2) | AU2013272330B2 (hr) |
| CA (1) | CA2875841C (hr) |
| DK (2) | DK3456334T3 (hr) |
| ES (2) | ES2847424T3 (hr) |
| HK (1) | HK1211847A1 (hr) |
| HR (1) | HRP20190162T1 (hr) |
| HU (1) | HUE042643T2 (hr) |
| LT (1) | LT2854826T (hr) |
| PL (2) | PL3456334T3 (hr) |
| SI (1) | SI2854826T1 (hr) |
| TR (1) | TR201901771T4 (hr) |
| WO (1) | WO2013184064A1 (hr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101915904B1 (ko) * | 2016-08-12 | 2018-11-06 | 한국식품연구원 | 락토바실러스 인테스티날리스를 포함하는 갱년기 예방 또는 치료용 조성물 |
| KR102120479B1 (ko) * | 2018-10-30 | 2020-06-09 | 주식회사 종근당바이오 | 프로바이오틱스를 유효 성분으로 포함하는 이차성 골다공증의 예방 또는 치료용 조성물 |
| CN113677798A (zh) * | 2019-02-05 | 2021-11-19 | 伊兰科美国公司 | 一种益生菌组合物和使用方法 |
| KR102080498B1 (ko) * | 2019-08-23 | 2020-02-24 | 정영옥 | 페룰산 및 유산균을 유효성분으로 포함하는 골감소증 개선 또는 예방용 식품 조성물 |
| JPWO2021112041A1 (hr) * | 2019-12-02 | 2021-06-10 | ||
| CN111718903A (zh) * | 2020-06-24 | 2020-09-29 | 江南大学 | 一种筛选可预防和/或治疗骨质疏松的药物的方法 |
| CN114711429B (zh) * | 2021-06-08 | 2023-11-17 | 青岛蔚蓝生物股份有限公司 | 一株具有增强骨健康作用的罗伊氏乳杆菌及其应用 |
| CN114634901B (zh) * | 2022-05-18 | 2022-08-30 | 微康益生菌(苏州)股份有限公司 | 一种促进骨骼健康的干酪乳杆菌lc16及其培养方法与应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005537236A (ja) * | 2002-06-13 | 2005-12-08 | ユニバーシティ・カレッジ・コークーナショナル・ユニバーシティ・オブ・アイルランド，コーク | プロバイオティック治療 |
| US7344867B2 (en) * | 2005-04-15 | 2008-03-18 | Eamonn Connolly | Selection and use of lactic acid bacteria for reducing inflammation in mammals |
| KR20110095929A (ko) * | 2005-07-26 | 2011-08-25 | 네스텍 에스.아. | 항비만제 및 항비만 식품 |
| CA2662710A1 (en) * | 2006-09-07 | 2008-03-13 | Mcgill University | Oral polymeric membrane feruloyl esterase producing bacteria formulation |
| US20080254011A1 (en) * | 2007-04-11 | 2008-10-16 | Peter Rothschild | Use of selected lactic acid bacteria for reducing atherosclerosis |
-
2013
- 2013-06-04 JP JP2015515983A patent/JP6193981B2/ja active Active
- 2013-06-04 HU HUE13800449A patent/HUE042643T2/hu unknown
- 2013-06-04 LT LTEP13800449.4T patent/LT2854826T/lt unknown
- 2013-06-04 US US14/405,496 patent/US20150150917A1/en not_active Abandoned
- 2013-06-04 CN CN201380029676.7A patent/CN104755091B/zh active Active
- 2013-06-04 SI SI201331342T patent/SI2854826T1/sl unknown
- 2013-06-04 EP EP18202594.0A patent/EP3456334B1/en active Active
- 2013-06-04 KR KR1020147036636A patent/KR20150028968A/ko not_active IP Right Cessation
- 2013-06-04 DK DK18202594.0T patent/DK3456334T3/da active
- 2013-06-04 AU AU2013272330A patent/AU2013272330B2/en active Active
- 2013-06-04 ES ES18202594T patent/ES2847424T3/es active Active
- 2013-06-04 KR KR1020207011037A patent/KR102191537B1/ko active IP Right Grant
- 2013-06-04 DK DK13800449.4T patent/DK2854826T3/en active
- 2013-06-04 ES ES13800449T patent/ES2711427T3/es active Active
- 2013-06-04 EP EP13800449.4A patent/EP2854826B9/en active Active
- 2013-06-04 TR TR2019/01771T patent/TR201901771T4/tr unknown
- 2013-06-04 PL PL18202594T patent/PL3456334T3/pl unknown
- 2013-06-04 PL PL13800449T patent/PL2854826T3/pl unknown
- 2013-06-04 CA CA2875841A patent/CA2875841C/en active Active
- 2013-06-04 WO PCT/SE2013/050646 patent/WO2013184064A1/en active Application Filing
-
2015
- 2015-12-28 HK HK15112740.1A patent/HK1211847A1/xx unknown
-
2016
- 2016-10-21 US US15/331,346 patent/US9968643B2/en active Active
-
2018
- 2018-01-23 AU AU2018200524A patent/AU2018200524B2/en active Active
- 2018-03-12 US US15/918,207 patent/US10232001B2/en active Active
-
2019
- 2019-01-23 US US16/254,994 patent/US10537598B2/en active Active
- 2019-01-24 HR HRP20190162TT patent/HRP20190162T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20190162T1 (hr) | Lactobacillus reuteri atcc pta 6475 za uporabu za sprječavanje ili liječenje gubitka kosti kod sisavaca | |
| HK1245130A1 (zh) | 酶組合物及其用於創傷愈合的用途 | |
| HK1191671A1 (zh) | 乾燥乳酸菌和新的組合物 | |
| PL2685994T3 (pl) | Bakterie probiotyczne wykazujące aktywność przeciwutleniającą i ich zastosowanie | |
| HK1212387A1 (en) | Lactic acid bacteria capable of preventing and or treating senescence and dementia | |
| HK1218836A1 (zh) | 協同細菌組合物和其製造方法和用途 | |
| HK1203367A1 (en) | Medical organogel processes and compositions | |
| EP2811897A4 (en) | MEDICAL TERMINAL AND APPLICATION METHOD | |
| ZA201300612B (en) | Novel bacteria and methods of use thereof | |
| PL2771041T3 (pl) | Kompozycje i ich zastosowanie w gojeniu się kości | |
| ZA201207377B (en) | Composition comprising probiotic bacteria for use in the treatment of immune disorders | |
| EP2925202A4 (en) | SMOOTH AND VOLUMINOUS FABRIC | |
| ZA201405858B (en) | Recombinant microorganisms and methods of use thereof | |
| EP2659898A4 (en) | MEANS FOR CREATING INTERFERON PRODUCTION WITH MILK ACID BACTERIA | |
| EP2814413A4 (en) | BONE FIXING ELEMENT AND METHODS OF USE | |
| EP2822627A4 (en) | STERILIZATION AND HUMIDIFICATION APPARATUS AND INCUBATOR | |
| EP2603221A4 (en) | GGF2 AND METHODS OF USE | |
| EP2814412A4 (en) | BONE FIXING ELEMENT AND METHODS OF USE | |
| HK1196535A1 (zh) | 鹽及醫藥用途 | |
| EP2896294A4 (en) | MICRORNA IN HUMAN MILK AND USE THEREOF | |
| SG11201504153QA (en) | Beverage with heart aid functional ingredients and process thereof | |
| EP2670438A4 (en) | SELECTION AND TREATMENT OF PATIENTS | |
| ZA201307058B (en) | Use of polyaminoisoprenyl derrivatives in antobiotic or antisertic treatment | |
| EP2900166A4 (en) | STERILIZATION CONTAINER AND METHOD OF ORGANIZATION | |
| PT2725930E (pt) | Soluções para esterilização e pasteurização sem molibdatos |